今开:0.0 | 昨收:1.19 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.4180108E7 |
Fran恪2017-07-15 01:23
$TrovaGene, Inc.(TROV)$ 今天是绝好的买入机会,我昨天进入的稍微早了一些。现在股价接近历史新低,未来一年半载可能到5以上。看好这个生物分子诊断公司的未来,除了有诊断产品,公司现在刚刚切入火热的癌症新药,你认为它就值40M市值吗?查看全文
$Trovagene(TROV)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-20-006938 Act: 34 Size: 4 MB 网页链接
$Trovagene(TROV)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-20-006933 Act: 34 Size: 172 KB 网页链接
$Trovagene(TROV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-055489 Size: 5 KB 网页链接
$Trovagene(TROV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-055491 Size: 5 KB 网页链接
$Trovagene(TROV)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-055492 Size: 5 KB 网页链接
$Trovagene(TROV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-20-054721 Size: 3 KB 网页链接
$Trovagene(TROV)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001628280-20-005682 Act: 34 Size: 72 KB 网页链接
$Trovagene(TROV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-20-049719 Size: 3 KB 网页链接
$Trovagene(TROV)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-20-049722 Size: 3 KB 网页链接